With respect, the price is either commercially sensitive or it's not, Mr. Pinnow. You can't release it in one country and say it's not commercially sensitive to release the price per dose in the U.S. but it is commercially sensitive to not release the price in Canada. I don't understand that.
Let me move on, then. According to the The Washington Post, Israel was able to accelerate rollout in part by paying $50 U.S. per dose of the Pfizer-BioNTech vaccine, nearly double the price paid by the EU. Did Canada pay a premium for any December deliveries of our vaccine or for any vaccines that we've secured to date?